Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
My Humble Opinion
|
Other People's Opinion
|
| A "Must Read" Blog for Insiders. -- Wall Street Journal | A bi-weekly podcast. Listen and call-in live online or download to your iPod! |
| Also see Pharma Marketing News OpEd Pieces |
RLS Foundation (aka GSK?) Calls for Boycott of Consumer Reports Over Ad SpoofPosted: November 14, 2007Consumer Reports (CR) -- published by Consumer Union -- recently launched its "Antidote to TV Drug Ads" series that intends to be "an entertaining new online video series that will track and report on such ads." Needless to say, the videos are YouTube-like spoofs. First up in the series is a spoof of GSK's Requip TV ad. CR doesn't say anything about this ad that I and other bloggers have not already said a long time ago. However, the publication does have a HUGE readership that I can only dream of! As a result, its attack on Requip drew the attention of the Restless Leg Syndrome Foundation, the supposedly grassroots patient advocacy group with suspicious monetary and corporate ties to GlaxoSmithKline (GSK), the marketer of Requip. The RLS Foundation issued a clarion call to its "members" to boycott the publication. For more information about this, including comments I received from a Mirapex user (aka, Mirapex buzz marketer), links to the CR video and RLS Foundation letter to CR, see today's post to Pharma Marketing Blog. For more posts in related topic areas, see: If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
|
Special Supplement Direct-to-Consumer Advertising Volume Two: DTC in the New Era 
DTC advertising is set for major changes in light of public criticism, but also in reaction to the changing reality of the marketplace where there is less need for a one size fits all solution. DTC must evolve and marketers must pay more attention to measuring and improving its effectiveness. Otherwise, billions of dollars will continue to be wasted. This volume is devoted to DTC best practices with a focus on techniques for improving DTC efficacy and return on investment, which is generally considered to be declining.
Order both Volume One and Volume Two and SAVE! (Click Here) Order and pay for Volume Two now using your credit card. ONLY $29.95
If you wish to be pay by check or credit card off-line, please use: |